These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36670456)

  • 1. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
    Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
    J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature.
    Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z
    J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic study of seromucinous carcinoma of ovary].
    Tang SX; Sun YH; Xu Y; Zhou XR; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):774-779. PubMed ID: 27821232
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
    Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
    Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
    Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
    J Gynecol Oncol; 2018 Mar; 29(2):e20. PubMed ID: 29400013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
    Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
    J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
    Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 11. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
    Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E
    J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
    Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
    Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
    Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM
    Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Mucinous Carcinoma with a Yolk sac Tumor-Like Component: A Report of Three Cases with a Literature Review for Prognostic Analysis.
    Tsujimura M; Fujimoto M; Minamiguchi S; Miyamoto T; Ueda A; Hamanishi J; Mandai M; Haga H
    Int J Surg Pathol; 2023 Aug; 31(5):765-771. PubMed ID: 36314449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis.
    Lee KR; Nucci MR
    Int J Gynecol Pathol; 2003 Jan; 22(1):42-51. PubMed ID: 12496697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
    Santoro A; D'Alessandris N; Travaglino A; Arciuolo D; Inzani F; Angelico G; Scaglione G; Valente M; Raffone A; Zannoni GF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1263-1267. PubMed ID: 35253183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
    Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
    Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
    Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
    Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.